Kurt Jaeckle

10PUBLICATIONS
113CO-AUTHORS
Immunogenetics (incl. genetic immunology)Biological adaptationMolecular targetsHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 17, 2026
Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience.

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Jan 16, 2026
Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.

Priscilla K Brastianos, Katharine Dooley, Susan Geyer

|Sep 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.

James J Harding, Do-Youn Oh, Teresa Macarulla Mercade

|Feb 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas.

Mohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson

|Oct 26, 2022
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.

Priscilla K Brastianos, Erin L Twohy, Elizabeth R Gerstner

Pageof 2

Frequent Collaborators

3 joint publications

Priya Kumthekar

2 joint publications

Mitesh J Borad

2 joint publications

Maria Martinez-Lage

2 joint publications

Sani H Kizilbash